Current Drug Safety
Title: Editorial
Volume: 2 Issue: 1
Author(s): Frank M. C. Besag
Affiliation:
Export Options
About this article
Cite this article as:
C. Besag M. Frank, Editorial, Current Drug Safety 2007; 2 (1) . https://dx.doi.org/10.2174/157488607779315417
DOI https://dx.doi.org/10.2174/157488607779315417 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Investigation of the Metabolism of Rufinamide and Its Interaction with Valproate
Drug Metabolism Letters AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
Current Gene Therapy CAR, The Continuously Advancing Receptor, in Drug Metabolism and Disease
Current Drug Metabolism The Role of IRE1 Signaling in the Central Nervous System Diseases
Current Neuropharmacology GABAA/Bz Receptor Subtypes as Targets for Selective Drugs
Current Medicinal Chemistry Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches
CNS & Neurological Disorders - Drug Targets Metabotropic Glutamate Receptors Modulate Periaqueductal Grey Descending Analgesic System
Central Nervous System Agents in Medicinal Chemistry Effect of Valerian Extract on GABRB3 Gene MRNA Expression and Sedation in BALB/C Mice
Current Bioactive Compounds Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca<sup>2+</sup> Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
CNS & Neurological Disorders - Drug Targets Epigenetic Effects Mediated by Antiepileptic Drugs and their Potential Application
Current Neuropharmacology 5-Lipoxygenase in the Central Nervous System: Therapeutic Implications
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Conotoxins-New Vistas for Peptide Therapeutics
Current Pharmaceutical Design Cellular Actions of Gabapentin and Related Compounds on Cultured Sensory Neurones
Current Neuropharmacology Contraception in Women with Medical Conditions
Current Women`s Health Reviews Drug-Resistance in Central Nervous System Tumors: From the Traditional Cell-Resistance Model to the Genetically Driven Approaches on Therapy
Current Pharmaceutical Biotechnology Immunogenic Issues Concerning Recombinant Adeno-Associated Virus Vectors for Gene Therapy
Current Gene Therapy Parkinson Disease Genetics: A "Continuum" from Mendelian to Multifactorial Inheritance
Current Molecular Medicine Synthesis and Evaluation of the Anticonvulsant Activity of 5-alkylthio-4- phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one Derivatives
Letters in Drug Design & Discovery Alzheimer’s Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function
Current Alzheimer Research Calixarene: A Versatile Material for Drug Design and Applications
Current Pharmaceutical Design